Covered recipient · General Payments record
STACEY PHELPS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$5,243.35
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $992.89 | 37 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $513.52 | 30 |
| REVANCE THERAPEUTICS, INC. | $249.24 | 3 |
| Galderma Laboratories, L.P. | $230.13 | 4 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.09 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845393 | CMS |
| ABBVIE INC. | $32.05 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845395 | CMS |
| ABBVIE INC. | $21.00 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845397 | CMS |
| ABBVIE INC. | $26.77 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845399 | CMS |
| ABBVIE INC. | $18.83 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845401 | CMS |
| ABBVIE INC. | $29.14 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845403 | CMS |
| ABBVIE INC. | $28.99 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845405 | CMS |
| ABBVIE INC. | $22.81 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845407 | CMS |
| ABBVIE INC. | $2.45 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845409 | CMS |
| ABBVIE INC. | $32.00 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845411 | CMS |
| ABBVIE INC. | $11.47 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845413 | CMS |
| ABBVIE INC. | $10.48 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845415 | CMS |
| ABBVIE INC. | $3.52 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845417 | CMS |
| ABBVIE INC. | $3.05 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845419 | CMS |
| ABBVIE INC. | $2.57 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845421 | CMS |
| ABBVIE INC. | $33.14 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845423 | CMS |
| ABBVIE INC. | $25.90 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845425 | CMS |
| ABBVIE INC. | $23.61 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845427 | CMS |
| ABBVIE INC. | $11.35 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845429 | CMS |
| ABBVIE INC. | $40.62 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845431 | CMS |
| ABBVIE INC. | $13.82 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845433 | CMS |
| ABBVIE INC. | $20.34 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845435 | CMS |
| ABBVIE INC. | $17.76 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845437 | CMS |
| ABBVIE INC. | $7.74 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845439 | CMS |
| ABBVIE INC. | $0.37 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845441 | CMS |
| ABBVIE INC. | $4.54 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845443 | CMS |
| ABBVIE INC. | $17.64 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845445 | CMS |
| ABBVIE INC. | $18.91 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845447 | CMS |
| ABBVIE INC. | $3.99 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845449 | CMS |
| ABBVIE INC. | $5.57 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107845451 | CMS |
| Galderma Laboratories, L.P. | $166.74 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145383756 | CMS |
| Galderma Laboratories, L.P. | $22.68 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145383758 | CMS |
| Galderma Laboratories, L.P. | $21.07 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145383760 | CMS |
| Galderma Laboratories, L.P. | $19.64 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145383762 | CMS |
| REVANCE THERAPEUTICS, INC. | $144.58 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147948518 | CMS |
| REVANCE THERAPEUTICS, INC. | $38.46 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147948520 | CMS |
| REVANCE THERAPEUTICS, INC. | $66.20 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147948522 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.